MediGene's vision is the expansion of the potentials in medicine
by means of utilizing biotechnology in a responsible manner.
We apply state-of-the-art technologies in the development of
innovative drugs for the treatment of cancer and autoimmune
diseases. MediGene pursues the strategy of integrating all core
areas of a modern biopharmaceuticals company from research to
drug development and commercialization.